Systematic design of cell membrane coating to improve tumor targeting of nanoparticles

Abstract

Cell membrane (CM) coating technology is increasingly being applied in nanomedicine, but the entire coating procedure including adsorption, rupture, and fusion is not completely understood. Previously, we showed that the majority of biomimetic nanoparticles (NPs) were only partially coated, but the mechanism underlying this partial coating remains unclear, which hinders the further improvement of the coating technique. Here, we show that partial coating is an intermediate state due to the adsorption of CM fragments or CM vesicles, the latter of which could eventually be ruptured under external force. Such partial coating is difficult to self-repair to achieve full coating due to the limited membrane fluidity. Building on our understanding of the detailed coating process, we develop a general approach for fixing the partial CM coating: external phospholipid is introduced as a helper to increase CM fluidity, promoting the final fusion of lipid patches. The NPs coated with this approach have a high ratio of full coating (~23%) and exhibit enhanced tumor targeting ability in comparison to the NPs coated traditionally (full coating ratio of ~6%). Our results provide a mechanistic basis for fixing partial CM coating towards enhancing tumor accumulation.

References 61

1. 1.

   Luo GF, Chen WH, Zeng X, Zhang XZ. Cell primitive-based biomimetic functional materials for enhanced cancer therapy. Chem. Soc. Rev. 2021;50:945-985.

   Not in our library10.1039/d0cs00152j

2. 2.

   Huang LL, Nie W, Zhang J, Xie HY. Cell-membrane-based biomimetic systems with bioorthogonal functionalities. Acc. Chem. Res. 2020;53:276-287.

   Not in our library10.1021/acs.accounts.9b00559

3. 3.

   Zeng Z, Pu K. Improving cancer immunotherapy by cell membrane‐camouflaged nanoparticles. Adv. Funct. Mater. 2020;30:2004397.

   Not in our library10.1002/adfm.202004397

4. 4.

   Izci M, Maksoudian C, Manshian BB, Soenen SJ. The use of alternative strategies for enhanced nanoparticle delivery to solid tumors. Chem. Rev. 2021;121:1746-1803.

   Not in our library10.1021/acs.chemrev.0c00779

5. 5.

   Liu Z, et al. Cell membrane-camouflaged liposomes for tumor cell-selective glycans engineering and imaging in vivo. Proc. Natl. Acad. Sci. USA. 2021;118:e2022769118.

   Not in our library10.1073/pnas.2022769118

6. 6.

   Xie X, et al. Unraveling cell-type-specific targeted delivery of membrane-camouflaged nanoparticles with plasmonic imaging. Nano Lett. 2020;20:5228-5235.

   Not in our library10.1021/acs.nanolett.0c01503

7. 7.

   Zhai Y, et al. T lymphocyte membrane-decorated epigenetic nanoinducer of interferons for cancer immunotherapy. Nat. Nanotechnol. 2021;16:1271-1280.

   Not in our library10.1038/s41565-021-00972-7

8. 8.

   Rao L, et al. Activating macrophage-mediated cancer immunotherapy by genetically edited nanoparticles. Adv. Mater. 2020;32:e2004853.

   Not in our library10.1002/adma.202004853

9. 9.

   Jiang Y, et al. Engineered cell-membrane-coated nanoparticles directly present tumor antigens to promote anticancer immunity. Adv. Mater. 2020;32:e2001808.

   Not in our library10.1002/adma.202001808

10. 10.
    Intratumoral immunotherapy using platelet-cloaked nanoparticles enhances antitumor immunity in solid tumors · 2021

    No notice
11. 11.

    Alsaiari SK, et al. Sustained and targeted delivery of checkpoint inhibitors by metal-organic frameworks for cancer immunotherapy. Sci. Adv. 2021;7:eabe7174.

    Not in our library10.1126/sciadv.abe7174

12. 12.

    Gong H, et al. Nanomaterial biointerfacing via mitochondrial membrane coating for targeted detoxification and molecular detection. Nano Lett. 2021;21:2603-2609.

    Not in our library10.1021/acs.nanolett.1c00238

13. 13.

    Ben-Akiva E, et al. Biomimetic anisotropic polymeric nanoparticles coated with red blood cell membranes for enhanced circulation and toxin removal. Sci. Adv. 2020;6:eaay9035.

    Not in our library10.1126/sciadv.aay9035

14. 14.

    Tang Z, et al. A materials-science perspective on tackling COVID-19. Nat. Rev. Mater. 2020;5:847-860.

    Not in our library10.1038/s41578-020-00247-y

15. 15.

    Nie C, et al. Spiky nanostructures with geometry-matching topography for virus inhibition. Nano Lett. 2020;20:5367-5375.

    Not in our library10.1021/acs.nanolett.0c01723

16. 16.

    Ai X, et al. Surface glycan modification of cellular nanosponges to promote SARS-CoV-2 inhibition. J. Am. Chem. Soc. 2021;143:17615-17621.

    Not in our library10.1021/jacs.1c07798

17. 17.

    Xu C, Jiang Y, Han Y, Pu K, Zhang R. A polymer multicellular nanoengager for synergistic NIR-II photothermal immunotherapy. Adv. Mater. 2021;33:e2008061.

    Not in our library10.1002/adma.202008061

18. 18.

    Gao X, et al. A virus-mimicking nucleic acid nanogel reprograms microglia and macrophages for glioblastoma therapy. Adv. Mater. 2021;33:e2006116.

    Not in our library10.1002/adma.202006116

19. 19.
    Arsenene-mediated multiple independently targeted reactive oxygen species burst for cancer therapy · 2021

    No notice
20. 20.

    Zhang Q, et al. Cellular nanosponges inhibit SARS-CoV-2 infectivity. Nano Lett. 2020;20:5570-5574.

    Not in our library10.1021/acs.nanolett.0c02278

21. 21.

    Fang RH, Kroll AV, Gao W, Zhang L. Cell membrane coating nanotechnology. Adv. Mater. 2018;30:e1706759.

    Not in our library10.1002/adma.201706759

22. 22.
    Cell membrane coating integrity affects the internalization mechanism of biomimetic nanoparticles · 2021

    No notice
23. 23.

    Wilhelm S, et al. Analysis of nanoparticle delivery to tumours. Nat. Rev. Mater. 2016;1:1-12.

    Not in our library10.1038/natrevmats.2016.14

24. 24.

    Tanaka M, Sackmann E. Polymer-supported membranes as models of the cell surface. Nature. 2005;437:656-663.

    Not in our library10.1038/nature04164

25. 25.

    Jackman JA, Cho NJ. Supported lipid bilayer formation: beyond vesicle fusion. Langmuir. 2020;36:1387-1400.

    Not in our library10.1021/acs.langmuir.9b03706

26. 26.

    Mornet S, Lambert O, Duguet E, Brisson A. The formation of supported lipid bilayers on silica nanoparticles revealed by cryoelectron microscopy. Nano Lett. 2005;5:281-285.

    Not in our library10.1021/nl048153y

27. 27.

    Corbo C, et al. Unveiling the in vivo protein corona of circulating leukocyte-like carriers. ACS Nano. 2017;11:3262-3273.

    Not in our library10.1021/acsnano.7b00376

28. 28.

    Shin S, Ault JT, Stone HA. Flow-driven rapid vesicle fusion via vortex trapping. Langmuir. 2015;31:7178-7182.

    Not in our library10.1021/acs.langmuir.5b01752

29. 29.

    Boucher PA, Joos B, Zuckermann MJ, Fournier L. Pore formation in a lipid bilayer under a tension ramp: modeling the distribution of rupture tensions. Biophys. J. 2007;92:4344-4355.

    Not in our library10.1529/biophysj.106.092023

30. 30.

    Murrell M, et al. Spreading dynamics of biomimetic actin cortices. Biophys. J. 2011;100:1400-1409.

    Not in our library10.1016/j.bpj.2011.01.038

31. 31.

    Evans E, Rawicz W. Entropy-driven tension and bending elasticity in condensed-fluid membranes. Phys. Rev. Lett. 1990;64:2094-2097.

    Not in our library10.1103/physrevlett.64.2094

32. 32.

    Fa N, Marques CM, Mendes E, Schroder AP. Rheology of giant vesicles: a micropipette study. Phys. Rev. Lett. 2004;92:108103.

    Not in our library10.1103/physrevlett.92.108103

33. 33.

    Drazenovic J, Ahmed S, Tuzinkiewicz NM, Wunder SL. Lipid exchange and transfer on nanoparticle supported lipid bilayers: effect of defects, ionic strength, and size. Langmuir. 2015;31:721-731.

    Not in our library10.1021/la503967m

34. 34.

    Karatekin E, et al. Cascades of transient pores in giant vesicles: line tension and transport. Biophys. J. 2003;84:1734-1749.

    Not in our library10.1016/s0006-3495(03)74981-9

35. 35.
    Regulation of lipid saturation without sensing membrane fluidity · 2020

    No notice
36. 36.

    Budin I, et al. Viscous control of cellular respiration by membrane lipid composition. Science. 2018;362:1186-1189.

    Not in our library10.1126/science.aat7925

37. 37.

    Tsunoda T, et al. Effects of lysozyme and bovine serum albumin on membrane characteristics of dipalmitoylphosphatidylglycerol liposomes. Colloids Surf. B: Biointerfaces. 2001;20:155-163.

    Not in our library10.1016/s0927-7765(00)00188-0

38. 38.

    Ashley CE, et al. The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers. Nat. Mater. 2011;10:389-397.

    Not in our library10.1038/nmat2992

39. 39.

    Zou M-Z, Li Z-H, Bai X-F, Liu C-J, Zhang X-Z. Hybrid vesicles based on autologous tumor cell membrane and bacterial outer membrane to enhance innate immune response and personalized tumor immunotherapy. Nano Lett. 2021;21:8609-8618.

    Not in our library10.1021/acs.nanolett.1c02482

40. 40.

    Wu H, et al. Engineering stem cell derived biomimetic vesicles for versatility and effective targeted delivery. Adv. Funct. Mater. 2020;30:2006169.

    Not in our library10.1002/adfm.202006169

Cited by papers we hold 2

• Recent advances of engineering cell membranes for nanomedicine delivery across the blood–brain barrier · 2025
  Not checked
• piR‐RCC Suppresses Renal Cell Carcinoma Progression by Facilitating YBX‐1 Cytoplasm Localization · 2025
  Not checked

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.